Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-15
2008-07-15
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S298000
Reexamination Certificate
active
07399774
ABSTRACT:
A compound of the formula (I) or a pharmaceutically acceptable salt, enantiomer, racemate, diastereomers or mixtures thereof, or a solvate thereof, formulations and methods of use thereof, as opioid receptor antagonists are disclosed wherein the variables are as described herein.
REFERENCES:
patent: 0 827 746 (1998-11-01), None
patent: WO 95/35316 (1995-12-01), None
patent: WO 96/36620 (1996-11-01), None
patent: WO 99/33806 (1999-07-01), None
patent: WO 01/46198 (2001-06-01), None
patent: WO 02/078693 (2002-10-01), None
patent: WO 2004/026305 (2004-04-01), None
Siegel Miles Goodman
Stucky Russell Dean
Takeuchi Kumiko
Davis Zinna N
Demeter John C.
Eli Lilly and Company
Ginah Francis O.
LandOfFree
6-substituted nicotinamide derivatives as opioid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-substituted nicotinamide derivatives as opioid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted nicotinamide derivatives as opioid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2804502